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Background: The inflammatory response triggered by cardiac surgery with cardiopulmonary bypass (CPB) is a
primary cause of postoperative atrial fibrillation (POAF). The objective of this study was to determine the
relationships between rs2249825 (C/G) polymorphism in high-mobility group box protein 1 (HMGB1) and POAF in
patients who underwent coronary artery bypass grafting (CABG) under CPB.
Methods: A prospective cohort study was carried out between February 2011 and January 2014. Patients who had
no history of atrial fibrillation undergoing CABG with CPB were recruited in this study, and were matched based on
preoperative characteristics. Blood samples were obtained before, and at 4, and 24 h after CPB. HMGB1 level was
measured by enzyme immunoassay. Patients were genotyped for single nucleotide polymorphisms of HMGB1
(rs2249825). Patients were genotyped for single nucleotide polymorphisms of HMGB1 (rs2249825) using
pyrosequencing method. The primary clinical end point was the incidence of POAF after surgery.
Results: After matching, a total of 128 patients undergoing elective CABG with CPB were eligible for analysis.
Plasma HMGB1 concentrations were increased 4 h after CPB (p <0.0001) and were still increased at 24 h (p <0.0001).
The frequencies of CC, CG, GG genotypes were 21 (56.8 %), 29 (37.8 %), and 2 (5.4 %) in patients with POAF and
81.3, 16.5, and 2.2 % in patients without POAF (p = 0.016). CG + GG genotype was associated with high HMGB1
levels compared with the genotype CC at 4 h (p = 0.023), and 24 h (p = 0.015) after CPB. Multivariate analysis
showed that age older than 60 years (OR = 1.40; 95 % CI: 1.03 to 1.89; p = 0.021) and allele G of polymorphisms
(OR = 1.61; 95 % CI: 1.08 to 2.04; p = 0.034) were independent risk factors for POAF.
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Conclusions: The HMGB1 rs2249825 was associated with the susceptibility to POAF after CABG with CPB in a
Chinese Han population.
Keywords: Atrial fibrillation, Coronary artery bypass grafting, Cardiopulmonary bypass, High-mobility group box
protein 1, PolymorphismBackground
Postoperative atrial fibrillation (POAF) is the most com-
mon complication encountered after cardiac surgery and
has important clinical and economic implications [1, 2].
The incidence of POAF reported in previous studies ran-
ging from 10 to 65 % of patients after cardiac surgery, de-
pending on definitions and methods of detection [3–5].
Although several studies have analyzed the risk factor for
POAF, the exact pathophysiology of this problem has not
already been illustrated. It has been demonstrated that an
increased inflammatory response correlates with the oc-
currence of POAF [6–8]. The complex inflammatory re-
sponse to cardiac surgery using cardiopulmonary bypass
(CPB) is one of the primary mechanisms in the pathogen-
esis of POAF. These inflammatory responses eventually
leads to abnormal anisotropic conduction such as inter-
leukin-6 (IL-6), IL-1, IL-8 and tumor necrosis factor-α
(TNF-α) which results in a decrease of the conduction
speed and in heterogeneous impulse propagation, which
facilitates the reentry and genesis of POAF [9, 10]. There-
fore, inflammation has been presumed to be implicated in
its pathogenesis. However, the intensity of this inflamma-
tory response is variable among patients and remains
unpredictable. Increased evidence for heritability of the
proinflammatory state suggests that individual genetic
background also plays roe in modulating the magnitude of
postoperative systemic inflammatory response after car-
diac surgery [11].
Genetic variants, particularly single-nucleotide poly-
morphisms (SNPs), are critical determinants for interin-
dividual differences in both inflammatory responses and
clinical outcomes in patient with on-pump primary iso-
lated coronary artery bypass surgery [2]. Given the broad
distribution, genetic polymorphisms offer a potential ex-
planation for the susceptibility of POAF after CABG.
High-mobility group box protein 1 (HMGB1) has
been demonstrated to be as an important mediator of
systemic inflammation. HMGB1 is highly conserved
among mammals, showing more than 98 % of sequence
identities between humans and other mammals [12].
HMGB1, as a nuclear DNA binding protein, has re-
cently been reported to be involved in triggering sterile
inflammation [13]. Extracellular HMGB-1 acts as an
alarm signal to induce inflammation, proliferation and
migration of immune cells [14, 15]. In addition, grow-
ing evidence has also indicated that HMGB1 plays acentral pathogenic role in critical illness [15–17].
Collectively, these suggest that HMGB1 could be in-
volved in the inflammatory responses to CABG with
CPB, and may be a common risk gene for POAF after
cardiac surgery.
In this study, we tested whether rs2249825 polymorph-




This was a nonrandomized, prospective observational
cohort study. To overcome bias in some baseline charac-
teristics between patients with and without POAF, the
discovery set actually were frequency-matched to the
case by age (±5 years), gender, and comorbidities includ-
ing diabetes, hypertension and previous myocardial
infarction.
From February 2011 to January 2014, a total of 128
patients undergoing elective CABG with CPB were
screened. All patients were placed on CPB. Exclusion
criteria included emergency surgery, a prior history of
AF, age > 80 years, left atrial volume (LAV) > 32 ml/m2,
left ventricular ejection fraction (LVEF) < 0.30, chronic
obstructive pulmonary disease (COPD), impaired renal
function and current infection. This study further ex-
cluded patients with necessitating intervention to the
mitral valve or POAF due to electrolyte imbalance.
All patients requiring surgical intervention received
standard surgical care and postoperative intensive care
unit treatment. The protocol for this study was approved
by the local institutional ethics committee, and the in-
formed consent was obtained from the patients or the
patients’ next of kin.
Surgical procedures
Standard median sternotomy was the selected surgical
access to the heart for all patients and the pericardial
edges were lifted. CPB was instituted using a Cobe
hollow fibre membrane oxygenator and the CPB flow
was regulated at 2.o to 2.4 L min−1 m−2, and moderate
hypothermia (32 to 34 °C) was accomplished. The mean
perfusion pressures were maintained at a range of 60 to
80 mmHg. Identical cold blood cardioplegic solution
was given after cross-clamping for myocardial protec-
tion. The distal vein graft anastomoses were performed
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tomoses to the diagonal branches and or left anterior de-
scending were performed last. The proximal vein graft
anastomosis was performed under side clamping of the
aorta. After declamping, the heart was defibrillated, if
needed, then the patient was rewarmed. After weaning
of the CPB and decanulation the heparin was reversed
with protamine sulphate.
Blood sample collection and assay
For each patient peripheral venous blood samples were
obtained through a central venous catheter at 3 different
time points, which are before, and at 4 and 24 h after
CPB. Samples were collected in potassium ethylenedi-
amine tetra-acetic acid (EDTA) coated bottles, and were
centrifuged at 5000 g for 5 min to remove the cellular
components. The plasma obtained was stored at −80 °C
for longer term storage.
The plasma samples were tested for HMGB1 levels by
enzyme-linked immunosorbent assay (ELISA), using a
commercially available human HMGB1 ELISA kit (USCN
Life Sciences, Wuhan, Hubei, China ), according to the
manufacturer’s instruction. The minimum detectable level
of HMGB1 was 12 pg/ml.
Postoperative evaluation and definition
After completion of the surgical procedure, patients
were admitted to intensive care unit and when their
haemodynamic and respiratory functions were stable,
they were transferred to wards. All patients were moni-
tored continuously with electrocardiographic (ECG) tel-
emetry equipment until postoperative day 5, and their
24-h report was reviewed by a study physician or a study
nurse coordinator every day for any episode of POAF. In
case of clinical suspicion of arrhythmia, a standard 12-
lead electrocardiogram was performed two times a day
from the first postoperative day until discharge. POAF
was defined as an irregular supraventricular rhythm
present in the absence of P waves, which was typically
sustained for more than 30 min. Therapeutic approaches
for treatment of POAF included standard pharmacologic
management and electric cardioversion if indicated. To
avoid investigators-related biases, all the physicians in-
volved in patients’ care were blinded to the results of the
genetic analyses.
Genomic DNA isolation and genotype analysis
Blood specimens were collected in tripotassium EDTA
sterile tubes from patients after admission. Genomic
DNA was extracted from whole blood using the Wizard
Genomic DNA Purification Kit (Promega, Madison, WI,
USA) according to the manufacturer’s protocol. The ex-
tracted DNA was stored at −20 °C until used. The
primers for the SNPs rs2249825 were 5′-TGTCTGATTTTACGGAGGTTGAT-3′ (forward) and 5′-GTTTG
CACAAAAAATGCATATGAT-3′ (reverse). The PCR
conditions were as follows: 5 min at 94 °C followed
by 35 cycles for 30 s at 94 °C, 30 s at 60 °C, and
30 s at 72 °C. The genotypes of the PCR products
were determined by pyrosequencing analysis using a
standard protocol as previously described [18]. Geno-
type was assigned as homozygous C/C, homozygous
G/G or heterozygous C/G.Statistical analysis
Categorical variables were presented as percentages and
continuous variables were expressed as mean ± SD. Cat-
egorical variables were compared by Chi-square analysis
or Fisher’s Exact Test as appropriate; continuous vari-
ables were compared with Student’s t test for normally
distributed values and with Mann–Whitney-Wilcoxon
test for non-normally distributed variables. The Chi-
square test was used to test the deviation of genotype dis-
tribution from the predicted genotype frequencies based
on the Hardy-Weinberg equilibrium. Before evaluating
the contribution of genetic factors, the relationship be-
tween traditional risk factors and POAF was identified
using first univariate analysis followed by multiple logistic
regression analysis. We selected variables for the multivar-
iable analysis if their p value was 0.05 or lower in the uni-
variable analysis and according to their clinical relevance.
The association between gene polymorphisms and
incidence of POAF was measured by a 2-stage analysis
approach as described in a previous study [19]. Firstly,
allelic associations with incident POAF were assessed
using χ2 tests. To avoid assumptions regarding the modes
of inheritance, all analyses were performed using additive
(homozygote major allele versus heterozygote versus
homozygote minor allele), dominant (homozygote major
allele versus heterozygote + homozygote minor allele), or
recessive (homozygote major allele plus heterozygote ver-
sus homozygote minor allele) models for each polymorph-
ism. Second, Odds ratios (OR) with 95 % confidence
intervals (CI) were calculated by logistic regression ana-
lysis to estimate the relative risk of POAF. All statistical
tests were two sided, and p value < 0.05 was considered
statistically significant. Statistical analyses were performed
using SPSS 17.0 (SPSS, Chicago, Illinois, USA).Results
During the study period, a total of 151 patients sched-
uled for CABG with CPB. Of the patients who were ini-
tially evaluated, 23 patients were excluded for having a
history of AF or COPD before their operation, LAV >
32 ml/m2 or LVEF < 0.30, impaired renal function, death
during the early days of ICU stay and CABG with valvu-
lar surgery. A total of 128 patients were finally recruited






Age (years) 65.7 ± 6.4 59.1 ± 7.6 0.002
Gender
Male 29 (78.4 %) 77 (84.6 %) 0.397
Female 8 (21.6 %) 14 (15.4 %)
Diabetes 12 (32.4 %) 29 (31.9 %) 0.951
Hypertension 24 (64.9 %) 55 (60.4 %) 0.641
Hypercholesterolemia 25 (67.6 %) 59 (64.8 %) 0.768
Previous myocardial infarction 15 (40.5 %) 37 (40.7 %) 0.99
Previous cerebral attack 3 (30 %) 7 (70 %) 0.937
Peripheral vascular disease 0 (0 %) 1 (1.1 %) 0.522
Chronic renal insufficiency 1 (2.7 %) 9 (9.9 %) 0.17
NYHA score
I 3 (8.1 %) 8 (8.8 %) 0.994
II 25 (67.6 %) 61 (67.0 %)
III 7 (18.9 %) 18 (19.8 %)
IV 2 (5.4 %) 4 (4.4 %)
Diseased vessels
1 1 (2.7 %) 2 (2.2 %) 0.967
2 4 (10.8 %) 9 (9.8 %)
3 32 (86.5 %) 80 (88.0 %)
LVEF≤ 50 % 6 (16.2 %) 13 (14.3 %) 0.781
Preoperative medications
Beta-blockers 30 (81.1 %) 78 (85.7 %) 0.513
ACEI/ARB 18 (48.6 %) 41 (45.1 %) 0.712
Ca2 + −channel blocker 19 (51.4 %) 51 (56.0 %) 0.629
Mean CPB time (min) 107.2 ± 35.4 79.1 ± 31.9 0.023
Mean aortic clamp time (min) 74.9 ± 25.1 48.6 ± 24.4 0.017
Mean intensive care unit stay (days) 5.2 ± 3.6 4.9 ± 2.7 0.81
POAF postoperative atrial fibrillation, LVEF left ventricular ejection fraction, CPB
cardiopulmonary bypass
Fig. 1 Relationship with genotype of the polymorphism in the HMGB1
gene and plasma HMGB1 concentrations before, 4, and 24 h after
cardiopulmonary bypass (CPB) in patients undergoing coronary artery
bypass grafting surgery. *p < 0.05
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these patients were male. Of these enrolled patients, 37
(28.9 %) presented at least one qualifying episode of
POAF after cardiac surgery. Clinical and demographic
characteristics of the study population are summarized
in Table 1. Results of the univariate analysis showed that
clinical factors associated with POAF included age (p =
0.002) and aortic clamp time (p = 0.017).
The mean plasma HMGB1 levels in these patients
were 25.1 ± 4.7 ng/ml before CPB, 75.7 ± 22.3 ng/ml 4 h
after CPB, and 93.1 ± 16.1 ng/ml 24 h after CPB. Patients
with genotype CG +GG had significantly higher HMGB1
levels compared with those of genotype CC at 4 h (85.1 ±
26.6 ng/ml vs 71.7 ± 19.3 ng/ml [p = 0.023]), and 24 h
(100.9 ± 24.6 ng/ml vs 89.7 ± 14.9 ng/ml [p = 0.015]) after
CPB (Fig. 1).Genotype frequency was 74.2 % (n = 95) homozygous
for the C allele, 3.1 % (n = 4) homozygous for the G
allele and 22.7 % (n = 29) were heterozygotes. The geno-
type distributions of the SNP were all consistent with
the Hardy–Weinberg equilibrium (p = 0.343). Univariate
analysis was performed to identify whether the rs2249825
polymorphism of HMGB1 was associated with POAF. Of
those patients with POAF (n = 37), 21 (56.8 %) were geno-
type CC; 14 (37.8 %) were genotype CG; and 2 (5.4 %) were
genotype GG (Table 2). Hence, allele G is associated with
increased risk of POAF after cardiac surgery. To predict
determinants of POAF, we included relevant clinical mea-
surements in a multivariate logistic regression model, age,
CPB time, aortic clamp time, and HMGB1 rs2249825
genotype. The multivariate analysis showed that age older
than 60 years (OR = 1.40; 95 % CI: 1.03 to 1.89; p = 0.021)
and allele G of polymorphisms (OR = 1.61; 95 % CI: 1.08 to
2.04; p = 0.034) were independent risk factors for POAF
after cardiac surgery. POAF is associated with an increased
risk of mortality and morbidity, predisposes patients to a
higher risk of stroke, requires additional treatment, and in-
creases the costs of the post-operative care.
Discussion
In this study, we investigated the association of SNP
rs2249825 in HMGB1 gene with POAF after CABG with
CPB in a Chinese Han population. The results showed
that the frequency of G genotype was significantly in-
creased in the patients with POAF, suggesting that there
was a positive association of this SNP with POAF.
POAF is one of the most common complication after
open cardiac surgery. Incidence of POAF after isolated
CABG is lower than that of valvular cardiac surgery but
is still estimated to affect approximately one-third of the
total patients [20, 21]. This number is estimated to rise
in a more aged patient population, as there is approxi-
mately 24 % increase in frequency of POAF with each
additional 5 years of age [22]. Previous studies showed
Table 2 Genotype for patients with or without POAF
Polymorphism N No POAF, n (%) POAF, n (%) χ2 P value
Additive model
CC 95 74 (81.3 %) 21 (56.8 %) 8.299 0.016
CG 29 15 (16.5 %) 14 (37.8 %)
GG 4 2 (2.2 %) 2 (5.4 %)
Dominant model
CC 95 74 (81.3 %) 21 (56.8 %) 8.294 0.004
CG + GG 33 17 (18.7 %) 16 (43.2 %)
Recessive model
CC + CG 124 89 (97.8 %) 35 (94.6 %) – 0.579*
GG 4 2 (2.2 %) 2 (5.4 %)
POAF postoperative atrial fibrillation
*Fisher’s Exact Test
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long-term risk of mortality independent of patient pre-
operative severity. The risk of long-term mortality in
patients that developed POAF was 29 % higher than in
patients without it [23]. Although, early POAF is com-
monly considered relatively easy to treat and is believed
to have little effect on patients’ outcomes, further re-
search in the area of the prevention and management of
POAF after cardiac surgery is needed [24, 25].
Evidence has suggested that atrial alteration of atrial
conduction properties in the right atrium by inflamma-
tion after cardiac surgery is the pathologic cause of
POAF [9, 26].
The acute systemic inflammatory reaction due to CPB
and generalized surgical trauma is a main determinant
of new-onset POAF and the modulation of inflammation
will probably represent a major therapeutic goal in the
short term and a promising pathway [27]. Chung et al.
[7] study have shown that inflammatory markers, al-
though generally increased after CPB, are particularly
high in those patients with POAF. In addition it has
been reported that interleukin-6 promoter variant ap-
pears to be implicated in inflammatory response to
surgery and development of POAF [2]. Collectively,
these data suggest that genetic factors may play a role in
the pathogenesis of POAF after cardiac surgery. In view
of the fact that inflammatory state after cardiac surgery
with CPB might in fact alter the underlying atrial elec-
trophysiology, we tested whether POAF was associated
with the plasma level of HMGB1 in a Chinese Han
population.
HMGB1 is a late-acting proinflammatory mediator,
identified by Wang and colleagues about 15 years ago.
This research led to the recognition that certain en-
dogenous molecules, which can be passively released by
stressed or necrotic cells or, in some cases, actively se-
creted by immunostimulated macrophages and certainother cell types, are capable of activating the innate im-
mune system and initiating or propagating inflammation
[28]. It has been reported that HMGB1 is associated
with systemic inflammation and remote organ dysfunction
resulting from sterile trauma, including bilateral femur
fracture, ischemia-reperfusion injury, and hemorrhagic
shock [29]. Proinflammatory activation signals induced by
injury trigger an active release of HMGB1 from activated
monocytes and macrophages; and it is also released pas-
sively by necrotic and damaged cells [14, 30]. HMGB1 re-
leased into the extracellular milieu act as a mediator to
further trigger the secretion of other cytokines, such as
tumor necrosis factor, IL-1, and IL-6, by macrophages and
other cell types [28]. Hence, extracellular HMGB1 func-
tions as a danger signal to responsive cells, amplifies the
signal by increasing production and secretion of other
proinflammatory cytokines and finally induces systemic
inflammation [31].
A total of 7 SNPs have been identified to date within
the human HMGB1 gene as shown by the public SNP
database (www.hapmap.org), but little has been known
about the biologic importance of these polymorphisms.
Although Kornblit et al. [32] identified 6 polymorphisms
within the entire HMGB1 gene by DNA sequence ana-
lysis of 103 healthy Caucasian Danish blood donors,
Only rs1060348 polymorphism was shown to be signifi-
cantly associated with outcome of patients with systemic
inflammatory response syndrome in the ICU. Zeng et al.
[33] selected 3 tag SNPs for the entire HMGB1 gene,
and only the rs2249825 polymorphism was significantly
associated with lipopolysaccharide–induced HMGB1 pro-
duction by peripheral leukocytes, showing how the
rs2249825 polymorphism determines HMGB1 levels.
Previous studies have identified a very interesting SNP
candidate. In a study by Chew et al. [34], the polymorph-
ism of apolipoprotein E gene, which was known to be
involved in mediating inflammatory and tissue repair re-
actions, was found to be associated with postoperative
renal dysfunction in cardiac surgery patients, suggesting
the possibility of a genetic modulation of postoperative
clinical outcome. Other study further showed evident
correlation between the polymorphism of Interleukin-6
gene promoter of the and the development of POAF,
strong augmenting in favor of an inflammatory compo-
nent in the development of POAF after cardiac surgery
[2]. Our results showed that the frequency of CG or CG+
GG genotype was significantly increased in patients with
POAF, indicating genetic predisposition play a role in this
common complication after cardiac surgery.
Conclusion
In conclusion, this study suggests that the CG/GG geno-
type of HMGB1 rs2249825 might cause susceptibility to
POAF after cardiac surgery in a Chinese Han population.
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its role are not completely understood yet and further
studies are needed to clarify this issue.
Limitations
It is worthwhile to point out that there are some limita-
tions in our study. First, as POAF is a common compli-
cation after cardiac surgery, the patients recruited from
CABG might represent a subpopulation of this problem.
Furthermore, the patients enrolled in this study were re-
cruited from Chinese Han individuals and the sample
size of patients included was relatively small. Thus, the
results presented here need to be confirmed using differ-
ent ethnic populations before to be extrapolated in the
general population. Second, a further limit of our proto-
col lies in the fact that continuous telemetry was used
only for the first 5 days after surgery and from this time
on patients were submitted to surface ECG every day in
case of clinical suspicion of arrhythmia. This methodology
could result in the missing of some episode of transient
asymptomatic atrial arrhythmia. Thirdly, we used a short
follow-up period (postoperative hospitalization) following
the study design of previous studies. Therefore, POAF epi-
sodes that occurred after hospital discharge were missed.
Finally, and importantly, it is necessary to clarify whether
the loci associated with POAF identified in the present
study is only a marker or a causative variant.
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